Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-02-12 7:33 pm Sale | 13G | BRIDGEBIO PHARMA INC BBIO | AMERICAN INTERNATIONAL GROUP INC. AIG | 3,381,412 2.8% | -3,383,180 (-50.01%) | View |
2021-02-10 10:39 am Purchase | 13G | BRIDGEBIO PHARMA INC BBIO | VANGUARD GROUP INC | 6,441,312 5.25% | 6,441,312 (New Position) | View |
2021-02-05 07:51 am Purchase | 13G | BRIDGEBIO PHARMA INC BBIO | BlackRock Inc. BLK | 6,517,544 5.3% | 6,517,544 (New Position) | View |
2021-01-26 4:23 pm Sale | 13D | BRIDGEBIO PHARMA INC BBIO | Eidos Therapeutics Inc. EIDX | 0 0% | -44,651,896 (Position Closed) | View |
2021-01-26 09:00 am Sale | 13D | Eidos Therapeutics Inc. EIDX | BridgeBio Pharma Inc. BBIO | 1,000 100% | -24,574,501 (-100.00%) | View |
2020-10-15 4:17 pm Purchase | 13D | BRIDGEBIO PHARMA INC BBIO | Eidos Therapeutics Inc. EIDX | 44,651,896 36.4% | 44,651,896 (New Position) | View |
2020-10-06 4:45 pm Unchanged | 13D | BRIDGEBIO PHARMA INC BBIO | KKR Genetic Disorder L.P. | 34,510,971 28.2% | 0 (Unchanged) | View |
2020-10-05 5:30 pm Unchanged | 13D | Eidos Therapeutics Inc. EIDX | BridgeBio Pharma Inc. BBIO | 24,575,501 63.7% | 0 (Unchanged) | View |
2020-06-01 5:09 pm Sale | 13D | BRIDGEBIO PHARMA INC BBIO | KKR Genetic Disorder L.P. | 34,510,971 28.4% | -2,389,690 (-6.48%) | View |
2020-02-14 4:21 pm Purchase | 13G | BRIDGEBIO PHARMA INC BBIO | PERCEPTIVE ADVISORS LLC | 6,706,268 5.4% | 120,000 (+1.82%) | View |
2020-02-14 4:00 pm Purchase | 13G | BRIDGEBIO PHARMA INC BBIO | Kumar Neil | 8,618,783 6.98% | 8,618,783 (New Position) | View |
2020-02-14 08:21 am Purchase | 13G | BRIDGEBIO PHARMA INC BBIO | AMERICAN INTERNATIONAL GROUP INC. AIG | 6,764,592 5.5% | 6,764,592 (New Position) | View |